- About Us
- Patients, Families & Visitors
- Health Professionals
- Research & Training
- Ways to Give
|About Us||Patients, Families & Visitors||For Health Professionals||Careers||Research & Training||Ways to Give|
October 19, 2006
London Health Sciences Centre
519-685-8500, ext. 58738
London Health Sciences Centre Launches First International SPECT/CT Education Series
(LONDON, Ontario) -London Health Sciences Centre (LHSC) has a rich history of excellence and innovation in patient care and teaching. In keeping with this reputation, LHSC is pleased to announce that, in partnership with GE Healthcare, it will host the first international Molecular Imaging Master Series Educational Program, entitled, “Introduction to Hybrid Imaging: Focus on SPECT/CT” on Friday, October 20th and Saturday, October 21st at LHSC’s CSTAR (Canadian Surgical Technologies & Advanced Robotics) facility at University Hospital. LHSC acquired a GE SPECT/CT, the latest in imaging technology, in December 2005.
The Molecular Imaging Master Series trains physicians on the clinical benefits of SPECT/CT and how it can influence patient management. The course balances class work and lecture time with hands-on image interpretation time. Small class sizes ensure active participation and the opportunity to ask questions of the experts.
This 2-day comprehensive course covers all aspects of SPECT/CT, including practical aspects of patient preparation, study acquisition and post processing with hands-on workstation experience.
Program instructors will be Dr. William F. Pavlosky, MD, FRCP(C), FACR, Course Director, SPECT/CT Master Series, Associate Professor, Diagnostic Radiology and Nuclear Medicine, Division of Nuclear Medicine, LHSC, Schulich School of Medicine and Dentistry, University of Western Ontario (Schulich Medicine), and Dr. Jean Luc Urbain, MD, PhD, FRCP, Professor of Nuclear Medicine, Chief and Chair of Nuclear Medicine, LHSC, Schulich Medicine.
Media are invited to meet the program instructors between 12:00 Noon and 1:00 p.m. on Friday, October 20th or Saturday, October 21st. They will answer questions about this latest in diagnostic technology and demonstrate its advantages for physicians and patients.
About the Nuclear Medicine Program at LHSC:
The Department of Nuclear Medicine at LHSC is part of the city-wide Nuclear Medicine program in London, and the Department of Radiology and Nuclear Medicine at Schulich Medicine. It is one of the largest Nuclear Medicine Departments in the world and performs 35,000 procedures each year covering all aspects of diagnostic and therapeutic Nuclear Medicine.
About GE Healthcare:
GE Healthcare provides expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery and biopharmaceutical manufacturing technologies that enable health care providers around the world to develop new ways to predict, diagnose, inform and treat diseases such as cancer, heart disease, neurological diseases and other conditions. For more information about GE Healthcare, visit www.gehealthcare.com.
About London Health Sciences Centre:
London Health Sciences Centre (LHSC) is one of Canada’s largest acute-care teaching hospitals and is dedicated to excellence in patient care, teaching and research. LHSC has pioneered many national and international medical breakthroughs. Located in London, Ontario, LHSC encompasses three sites, South Street Hospital, University Hospital and Victoria Hospital; two family medical centres; and the London Regional Cancer Program. LHSC is the home of the Children’s Hospital of Western Ontario and CSTAR (Canadian Surgical Technologies & Advanced Robotics). The research arm of LHSC is Lawson Health Research Institute, which is partnered with London’s other teaching hospital, St. Joseph’s Health Care, London. LHSC is affiliated with The University of Western Ontario. Physicians and staff at LHSC number close to 8,000 and together they provide care for more than 600,000 patients each year.